Latest news
25 items- SECSEC Form 15-12G filed by Enfusion Inc.15-12G - Enfusion, Inc. (0001868912) (Filer)
- SECSEC Form EFFECT filed by Enfusion Inc.EFFECT - Enfusion, Inc. (0001868912) (Filer)
- INSIDERLarge owner Iconiq Strategic Partners V, L.P. disposed of 9,009,594 shares (SEC Form 4)4 - Enfusion, Inc. (0001868912) (Issuer)
- INSIDERDirector Luo Roy returned 9,009,594 shares to the company (SEC Form 4)4 - Enfusion, Inc. (0001868912) (Issuer)
- PROPENLANE Names Brad Herring Chief Financial OfficerBolsters Leadership Bench With More Than 30 Years of Financial Management and Investor Relations Expertise CARMEL, Ind., April 22, 2025 /PRNewswire/ -- OPENLANE, Inc. (NYSE:KAR), a leading operator of digital marketplaces for wholesale used vehicles, announces the company has named Brad Herring as EVP and Chief Financial Officer effective May 27, 2025. Herring will be responsible for leading all financial, reporting and investor-facing functions across OPENLANE, including the company's capital investment strategy. Herring also joins OPENLANE's executive team and will report to CEO Peter Kelly.
- INSIDERChief Operating Officer Pawar Neal returned 1,217,308 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Enfusion, Inc. (0001868912) (Issuer)
- INSIDERChief Financial Officer Herring Bradley returned 324,689 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Enfusion, Inc. (0001868912) (Issuer)
- INSIDERChief Executive Officer Movchan Oleg returned 1,783,665 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Enfusion, Inc. (0001868912) (Issuer)
- INSIDERDirector Leibowitz Lawrence E returned 175,572 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Enfusion, Inc. (0001868912) (Issuer)
- INSIDERDirector Hauser Jan returned 57,925 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Enfusion, Inc. (0001868912) (Issuer)
- INSIDERChief Accounting Officer Gutowski Valeria returned 47,622 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Enfusion, Inc. (0001868912) (Issuer)
- INSIDERGeneral Counsel Campobasso Matthew returned 70,946 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Enfusion, Inc. (0001868912) (Issuer)
- INSIDERDirector Somers Deirdre returned 41,675 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Enfusion, Inc. (0001868912) (Issuer)
- INSIDERDirector Derose Kathleen returned 60,716 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Enfusion, Inc. (0001868912) (Issuer)
- INSIDERDirector Spellacy Michael returned 56,810 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Enfusion, Inc. (0001868912) (Issuer)
- INSIDERChief People Officer Bastone Bronwen returned 213,051 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Enfusion, Inc. (0001868912) (Issuer)
- INSIDERDirector Bernstein Bradford E returned 32,440,463 shares to the company (SEC Form 4)4 - Enfusion, Inc. (0001868912) (Issuer)
- SECSEC Form POS AM filed by Enfusion Inc.POS AM - Enfusion, Inc. (0001868912) (Filer)
- SECSEC Form S-8 POS filed by Enfusion Inc.S-8 POS - Enfusion, Inc. (0001868912) (Filer)
- SECSEC Form S-8 POS filed by Enfusion Inc.S-8 POS - Enfusion, Inc. (0001868912) (Filer)
- SECSEC Form S-8 POS filed by Enfusion Inc.S-8 POS - Enfusion, Inc. (0001868912) (Filer)
- SECSEC Form S-8 POS filed by Enfusion Inc.S-8 POS - Enfusion, Inc. (0001868912) (Filer)
- SECEnfusion Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - Enfusion, Inc. (0001868912) (Filer)
- PRClearwater Analytics Finalizes Acquisition of EnfusionClearwater Will Deliver Industry's First Unified, Cloud-Native Front-to-Back Platform for Institutional Investors Clearwater Analytics (NYSE:CWAN), the most comprehensive technology platform for investment management, today announced the successful completion of its acquisition of Enfusion, Inc. (NYSE:ENFN), a leader in software-as-a-service (SaaS) solutions for the investment management and hedge fund sectors, in a deal valued at approximately $1.5 billion. This strategic combination positions Clearwater as the industry's first single-instance, multi-tenant, cloud-native platform to unify front, middle, and back-office investment operations. By integrating portfolio and order management,
- SECSEC Form 25-NSE filed by Enfusion Inc.25-NSE - Enfusion, Inc. (0001868912) (Subject)
ENFN FAQ
7 questionsWhat does Enfusion Inc. do?
Enfusion Inc. offers software-as-a-service for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and order and execution management system that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of...Where does ENFN stock trade?
Enfusion Inc. (ENFN) is listed on NYSE.What sector and industry is ENFN in?
Enfusion Inc. operates in the Technology sector, Computer Software: Prepackaged Software industry.When did Enfusion Inc. go public?
Enfusion Inc. (ENFN) completed its IPO in 2021.What are analysts saying about ENFN?
Enfusion Inc. has had 8 recent analyst actions on file. The most recent action was from Morgan Stanley: Overweight with a $1100.00 price target on 2024-05-10. Recent price targets range from $800.00 to $1200.00.What companies are similar to ENFN?
Notable peers in the same industry include MSFT (Microsoft Corporation), ORCL (Oracle Corporation), SAP (SAP SE), CRWD (CrowdStrike Holdings Inc.), CRM (Salesforce Inc.). Compare ENFN side-by-side with any of them on Quantisnow.How can I track ENFN on Quantisnow?
Quantisnow aggregates Enfusion Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ENFN to receive live email and push alerts on every new disclosure.